| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/03/1994 | WO1994004569A1 Use of specific binding molecules in potentiating igf-i activity |
| 03/03/1994 | WO1994004566A1 Lipopolysaccharide-binding protein and process for producing the same |
| 03/03/1994 | WO1994004565A2 Ipnv vaccine |
| 03/03/1994 | WO1994004564A1 T cell epitopes of ryegrass pollen allergen |
| 03/03/1994 | WO1994004562A1 Mammalian gap-43 compositions and methods of use |
| 03/03/1994 | WO1994004561A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | WO1994004560A1 Schwann cell mitogenic factor, its preparation and use |
| 03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004523A1 Dioxacycloalkane compound with renin-inhibiting activity |
| 03/03/1994 | WO1994004492A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/03/1994 | WO1994004382A1 Timing valve for the discontinuous metering of a volume flow |
| 03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
| 03/03/1994 | WO1994004196A1 Tumour therapy |
| 03/03/1994 | WO1994004190A1 Regulation of cellular invasiveness |
| 03/03/1994 | WO1994004188A1 Method for treating an lfa-1-mediated disorder |
| 03/03/1994 | WO1994004186A1 Homeopathic compositions for the treatment of viral and metabolic diseases |
| 03/03/1994 | WO1994004185A2 Method of inhibiting reduction of disulfide bonds |
| 03/03/1994 | WO1994004184A2 Method of decreasing cutaneous senescence |
| 03/03/1994 | WO1994004183A1 Methods for effecting a prolonged reduction in measurable fat content and medicaments for use therein |
| 03/03/1994 | WO1994004182A1 Method of treating asthma |
| 03/03/1994 | WO1994004181A1 Heparin neutralization with multimeric peptides |
| 03/03/1994 | WO1994004180A2 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 03/03/1994 | WO1994004179A1 Method for inhibiting hiv replication using il-4 |
| 03/03/1994 | WO1994004178A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | WO1994004177A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | WO1994004176A1 Novel peptides for heparin anticoagulation reversal |
| 03/03/1994 | WO1994004175A1 Hgf production promoter |
| 03/03/1994 | WO1994004174A1 Cytokine applications |
| 03/03/1994 | WO1994004173A1 Therapeutic compositions and methods for inhibiting il-8-mediated inflammation |
| 03/03/1994 | WO1994004172A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004170A1 Method of treating epstein-barr virus infection |
| 03/03/1994 | WO1994004168A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 03/03/1994 | WO1994004154A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE-NUCLEOSIDES |
| 03/03/1994 | WO1994004137A1 Antisense oligonucleotides to cyclin d1 proto-oncogene |
| 03/03/1994 | WO1994004121A1 Bystander suppression of retroviral-associated neurological disease |
| 03/03/1994 | WO1994004033A1 Anti-microbial composition |
| 03/03/1994 | WO1994004030A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 03/03/1994 | WO1993010747A3 Technetium-99m labeled peptides for imaging |
| 03/03/1994 | DE4328329A1 Freeze-dried polysaccharide bio-matrix useful as pharmaceutical or cosmetic carrier - comprises mixt. of natural and modified material e.g. pectin, alginate, agar, cellulose ether deriv. etc. |
| 03/03/1994 | DE4229166A1 Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse Means for maintaining and / or increasing muscle performance and body cell mass |
| 03/03/1994 | CA2224048A1 Test kit for testing microbiologically-contaminated material |
| 03/03/1994 | CA2143453A1 Regulation of cellular invasiveness |
| 03/03/1994 | CA2143308A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2142990A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | CA2142989A1 A novel b-lymphoma cell line and antigen |
| 03/03/1994 | CA2142883A1 Dioxacycloalkane compound having renin-inhibitory activity |
| 03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | CA2142863A1 Homeopatic compositions for the treatment of viral and metabolic diseases |
| 03/03/1994 | CA2142860A1 Human interleukin-13 |
| 03/03/1994 | CA2142839A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 03/03/1994 | CA2142456A1 Anti-microbial composition |
| 03/03/1994 | CA2142455A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/03/1994 | CA2142295A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | CA2141861A1 Use of specific binding molecules in potentiating igf-i activity |
| 03/03/1994 | CA2141602A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | CA2141598A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | CA2141457A1 Cytokine applications |
| 03/03/1994 | CA2140933A1 Method for treating an lfa-1 mediated disorder |
| 03/03/1994 | CA2140280A1 Bispecific immunoadhesins |
| 03/02/1994 | EP0585168A2 Composition and methods for the generation of bone |
| 03/02/1994 | EP0585155A1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition |
| 03/02/1994 | EP0585151A1 Process to prepare micropheres for the sustained release of LHRH-hormone, microspheres and so-obtained compositions |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585042A1 Antibiotic stalobacins |
| 03/02/1994 | EP0584876A2 Low diol polyalkylene oxide biologically active proteinaceous substances |
| 03/02/1994 | EP0584845A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/02/1994 | EP0584715A2 Isolation and culturing of transformed cells and preparation of antibodies against them |
| 03/02/1994 | EP0584694A1 Imidazolidin derivatives |
| 03/02/1994 | EP0584558A2 A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein |
| 03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 03/02/1994 | EP0584446A2 Microsomal triglyceride transfer protein |
| 03/02/1994 | EP0584374A1 Peptide which inhibits phospholipase c |
| 03/02/1994 | EP0584368A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 03/02/1994 | EP0584360A1 Wf11243 substance |
| 03/02/1994 | EP0584339A1 Method of delivering therapeutic substances to the brain |
| 03/02/1994 | EP0584290A1 Endothelin antagonists |
| 03/02/1994 | EP0584287A1 Use of müllerian inhibiting substance for treatment of certain tumors |
| 03/02/1994 | EP0584286A1 Use of platelet derived growth factor in the preparation of a medicament for the treatment of gastrointestinal ulcers |
| 03/02/1994 | EP0584283A1 Osteoinductive protein mixtures and purification processes |
| 03/02/1994 | EP0584279A1 Targeted delivery of genes encoding immunogenic proteins |
| 03/02/1994 | EP0584273A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
| 03/02/1994 | EP0584267A1 Tumor associated monoclonal antibody 81av78 |
| 03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 03/02/1994 | EP0584256A1 Method for detecting an localizing tissues having neurokinine 1 receptors |
| 03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
| 03/02/1994 | EP0584247A1 Compositons for the treatment of chronic fatigue syndrome |
| 03/02/1994 | EP0584245A1 Enzyme systems |
| 03/02/1994 | EP0584244A1 Peptide inhibitors of inflammation |
| 03/02/1994 | EP0584238A1 INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584228A1 New thermoplastic polymeric material and process for making same |
| 03/02/1994 | EP0584220A1 Engineering the local inflammatory response as a means of controlled release drug delivery |
| 03/02/1994 | EP0584214A1 Gene manipulation and expression using genomic elements |
| 03/02/1994 | EP0584201A1 Transmission-blocking vaccine against malaria |
| 03/02/1994 | EP0584194A1 Assays for inhibitors of leukocyte adhesion |
| 03/02/1994 | EP0584185A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 03/02/1994 | EP0584175A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |